Immunovant, Inc. (IMVT)
IMVTImmunovant, Inc.loading…
loading…
QTick signal
-4net
1 bull / 3 bear factors · leaningBull 1 pts·Bear 5 pts30d
loading…
Market context—Sector read · not on fileOKBalance sheet · Safe—Inflation-report days · not on fileOKCalm trading · sharp-drop risk 0/100 · Nov 9
Golden cross
50-day average is above the 200-day — an uptrend
Momentum (RSI)66.3fires under 35 · fires below the slider range
Price vs. profitno profit to compare
Price vs. its own pastnot on file
Last session traded heavier than its own normal. Over the last 20 sessions, 44% of the volume traded on days the stock closed lower.
Entry strategy · 10 triggers
1 of 6 aligned — not yetRSI 14
●
66.3
fires under 35 · fires below the slider range
vs 50-day
●
$32.98
above the line · fires near $33.23
Bollinger
●
$25.68
no lower pierce · fires near $26.85
VWAP 20
●
$29.44
above the rolling VWAP · fires near $29.43
Entry level
●
$34.18
level below · fires near $34.52
Put wall
✓
$37.00
2026-11-20 expiry · chain of 2026-11-10
MACD
Context✓
+0.42
histogram above zero · fading
RVolStatic
2.68×
heavier than its own normal
Short int.Static
23.2%
23.2% of float short — crowded
ATRStatic
$1.49
14-session average true range
A checklist, not odds on a return: 4 of 6 usable price conditions have to line up. RSI, the 50-day average and the Bollinger band move with the price you set; the 20-day average traded price, the entry level and the busiest put strike stay fixed. MACD, RVol, Short int. and ATR are context only — they never count toward the total.
Next earnings
2027-02-05
in 59 sessions
Next dividend
No indicated yield
no forward dividend on file